Novartis has halted distribution of generic Zantac. Here's what you need to know.

4:49am PDT - September 19th, 2019    zantac - CBS News

A version of a popular heartburn medicine is now on hold. There are concerns that the generic version of the drug known as Zantac may cause cancer. Novartis stopped the distribution of its prescription version as a precaution. The move comes after the FDA ann…